GLP-Class Research Compounds in the UAE: A Practical Guide to the Questions Buyers Ask

Last reviewed: May 2026

The GLP-class research compounds are the fastest-growing category in UAE peptide search in 2026. The clinical-trial data behind their licensed-medicine analogues is the most-publicised compound research of the decade. The research-grade versions have entered the local catalogue under codename for compliance reasons. Buyer questions arrive with high frequency and high stakes. This is the practical guide.

What the codenames refer to

For advertising-platform compliance reasons, NuroCore refers to three GLP-class compounds by codename rather than their licensed-medicine names. The codenames are:

• SG: the GLP-1 receptor agonist line. The most-studied in published research, with the longest clinical track record under its licensed analogue.
• MNJ: the dual GLP-1 and GIP receptor agonist line. Phase 3 trials of the licensed analogue showed larger body-composition effects than single-receptor compounds at matched cohorts.
• RT: the triple receptor agonist line (GLP-1, GIP, glucagon). Newest of the three and the most aggressive in published trial data, with the largest absolute effect and the steepest titration requirements.

The codename system is operational, not legal. Our UAE legal briefing covers the regulatory context.

The most-asked operational questions

What dose pattern do research protocols use? Once-weekly subcutaneous injection on a consistent day of the week. The plasma kinetics of these compounds support weekly rather than daily dosing. Day-of-week consistency matters more than time-of-day timing.

How long are the cycles? The published Phase 3 trials of the licensed analogues ran 68 weeks. Research-context protocols often run shorter cycles (24 weeks is common) followed by maintenance dose or break. The full response curve takes most of the 68-week window to develop.

What about side effects? The most-reported side effects are gastrointestinal: nausea, slower digestion, occasional constipation, particularly during titration. The published trials specifically designed graduated dose schedules to minimise GI burden. Persistent or severe side effects after the titration window are a clinical conversation, not a research-context one.

How do I time it around training, meals, sleep? Within-day timing has minimal effect on outcomes. The compound is in plasma at meaningful levels for the entire week. Research-protocol patterns typically choose a consistent day for ease of routine adherence rather than for physiological optimisation.

What about reconstitution? The research-grade compound arrives lyophilised. Reconstitute with bacteriostatic water following the standard pattern. The Dosage Calculator handles the syringe-units conversion. Reconstituted GLP-class compounds typically have longer stability windows than other peptides because the molecular structure is more thermally stable. Standard 28-day fridge storage applies as the conservative default.

What pairs with the protocol

This is where the supplement layer matters more than for most other compound classes. People running GLP-class protocols tend to under-eat as appetite drops, which means under-consuming sodium, potassium, and protein. The supplement-layer support that earns its place:

• Hydra Core for electrolyte replacement at the research-supported sodium ratio. UAE summer heat amplifies the relevance.
• Adequate dietary protein at the higher end of the research-supported range (1.6 to 2.2 g/kg per day). Our protein synthesis piece covers the dose math for older adults specifically.
• BPC-157 commonly stacked for tissue repair under reduced caloric intake

Which line should you pick

This is a clinical question, not a research-blog question. The published literature describes different effect sizes and side-effect profiles across the three lines. The choice depends on baseline metabolic markers, training context, age, and clinician input. The website cannot answer this. A UAE-licensed healthcare professional who knows your full medical context can.

What the published research actually shows by line

For reference, not as a recommendation:

• SG line: ~15% body weight reduction at 68 weeks in trial cohorts. Cleanest side-effect profile.
• MNJ line: ~22% body weight reduction at 72 weeks. Side-effect profile broadly similar to SG.
• RT line: ~24% body weight reduction at 48 weeks. Steepest titration, slightly higher GI side-effect rates.

Those figures are from the licensed-medicine trials. Research-context use sits in a different regulatory category. The trial data is reference material, not a prediction of what any individual will experience.

UAE-specific operational notes

Same UAE cold-chain dispatch as every other compound in the catalogue. Same AED-native pricing. Same Cash on Delivery option. The discreet outer packaging matters more for this compound class than for most, because GLP-class compounds attract more social attention than recovery peptides. The standard plain-carton dispatch handles this without special arrangements.

For buyers in other GCC countries, see the country-specific delivery guides: KSA, Kuwait, Qatar, Bahrain, Oman.

Where to start

For UAE-based researchers placing a first GLP-class research-context order:

1. Open the Protocol Builder, select the Composition goal
2. Review the curated starter stack including the supplement-layer support
3. Read our GLP timeline piece to understand the full response curve
4. Add bacteriostatic water and supplies to the order
5. Place the order with delivery to your UAE address

The clinical line

The GLP-class compounds are research-grade, sold for laboratory and research use. They are not approved as medicines. They are not licensed dietary supplements. Whether the protocol belongs in a specific person’s situation is a clinical question that benefits from clinician input. The Phase 3 trial data is reference material, not a personalised prescription.

Read next

• GLP-Class Compounds: A Clinical Timeline of When Results Actually Show
• Protein Synthesis After 40: Anabolic Resistance and What Actually Works
• Buying Peptides in the UAE: The Patient Guide for 2026